2025-00543Notice

Big Pharma Wants Special Trade Zone for Drug Research

Published Date: 1/14/2025

Notice

Summary

Merck, Sharp & Dohme LLC wants to expand their special Foreign-Trade Zone (FTZ) production in Rahway, New Jersey, to include new pharmaceutical drugs for metabolic and immunological disorders. This means they can bring in certain materials duty-free or with reduced duties, saving money and speeding up research. Public comments on this plan are open until February 24, 2025.

No Economic Impacts Identified for this Document

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
1/14/2025

Department and Agencies

Department
Independent Agency
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register